RxDoctor Payments Data

Robert Meyer

Internal Medicine · Orlando, FLNPI 1265465009

Payments from drug & device makers

$2,257,309in general payments, 2019–2025

Across 690 payments — averaging $3271.46 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Eli Lilly$797K
  • Eisai Inc.$478K
  • Biogen$342K
  • Sanofi Pasteur Inc.$298K
  • Astrazeneca UK Limited$163K
  • Vertex$92K
  • plus $87K from 4 others
$18,197in research payments, 2019–2025

Across 5 payments — averaging $3639.40 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Eli Lilly$18K

What the payments were for

  • Travel & lodging$2,50376%
  • Food & beverage$78624%

General payments by program year

22
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,257,309 in reported general payments places this provider in the 95th percentile of 8,530 internal medicine providers in Florida.

See all internal medicine providers in Florida

Other internal medicine in Orlando

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →